Cresset has launched Versaphor, a desktop applications division aimed at supplying tools based on its molecular Field technology.
Versaphor will provide tools to a range of markets, including medicinal chemists, patent teams (internal and external counsel), preclinical safety teams and in-licensing teams.
The division's Field-based tools enable companies to find smarter answers to their chemistry questions and make quicker, better-informed decisions about which molecules deserve the investment of time, effort and capital.
Versaphor's first products are medicinal-chemistry and patent-specific versions of the Fieldstere bioisostere generator.
The medicinal-chemistry application allows medicinal chemists to generate ideas for drug-like lead molecules in new areas of chemical space.
The patent application enables patent attorneys to identify and more accurately evaluate the 'obviousness' of new chemical filings and to develop stronger patent filings covering a wider range of structural diversity.
Cresset's Field-based tools are used by computational chemists to predict and compare the activity and properties of their lead compounds.
Instead of relying on 2D structure, Cresset uses the Field technology around molecules to assess their likely biological activity and properties, regardless of structural similarity.
Cresset's Field tools provide an accurate, condensed representation of the nature, size and location of the critical properties required for binding and instigating a specific therapeutic effect.
